Provided by Tiger Fintech (Singapore) Pte. Ltd.

Alpha Metallurgical Resources Inc

120.25
-3.9750-3.20%
Volume:149.70K
Turnover:18.07M
Market Cap:1.57B
PE:8.42
High:125.94
Open:125.35
Low:118.33
Close:124.22
Loading ...

B. Riley Adjusts Alpha Metallurgical Resources' Price Target to $183 From $272, Keeps Buy Rating

MT Newswires Live
·
11 Apr

Theriva Biologics Announces Presentation of Data from the Phase 1b/2a Clinical Trial of SYN-004 (ribaxamase) in Allogeneic Hematopoietic Cell Transplant Recipients

GlobeNewswire
·
10 Apr

Trump Set to Sign Executive Orders to Boost US Coal

Reuters
·
08 Apr

SCYNEXIS to Present Preclinical Data on Second Generation IV/Oral Fungerp SCY-247 at the European Society of Clinical Microbiology and Infectious Diseases (ESCMID)

GlobeNewswire
·
08 Apr

Simpson to Outfit AMR IndyCar Safety Team in 2025 Season

Business Wire
·
03 Apr

CASI Pharmaceuticals Announces Fourth Quarter and Full-Year 2024 Business and Financial Results

ACCESS Newswire
·
31 Mar

MicroVision Announces Fourth Quarter and Full Year 2024 Results

ACCESS Newswire
·
27 Mar

Blujepa (gepotidacin) Approved by US FDA for Treatment of Uncomplicated Urinary Tract Infections (uUTIs) in Female Adults and Pediatric Patients 12 Years of Age and Older

Business Wire
·
26 Mar

Oncocyte Reports Successful 2024; Sets Stage for 2025 Catalysts

GlobeNewswire
·
25 Mar

Kudan Integrates Visual SLAM with NVIDIA Isaac Perceptor, Enhancing AMR Capabilities

TIPRANKS
·
19 Mar

bioMérieux receives FDA 510(k) Clearance for its VITEK® COMPACT PRO, a new ID/AST system to fight against antimicrobial resistance

PR Newswire
·
19 Mar

If You Invested $1000 in Itron a Decade Ago, This is How Much It'd Be Worth Now

Zacks
·
13 Mar

Seres Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Updates

GlobeNewswire
·
13 Mar

Biogen Initiates Phase 3 Study of Felzartamab for the Treatment of Late Antibody-Mediated Rejection (AMR) in Kidney Transplant Patients

GlobeNewswire
·
11 Mar

Undervalued Small Caps With Insider Action To Watch In March 2025

Simply Wall St.
·
11 Mar

Brokers are tipping these super strong ASX 200 growth shares to rise 20%+

MotleyFool
·
06 Mar

B. Riley Cuts Price Target on Alpha Metallurgical Resources to $272 From $327, Keeps Buy Rating

MT Newswires Live
·
04 Mar

Alpha Metallurgical Resources (NYSE:AMR) Sees Stock Fall 12% After US$2 Million Q4 Loss

Simply Wall St.
·
04 Mar

Seres Therapeutics Receives Feedback From FDA on SER-155 Allogeneic Hematopoietic Stem Cell Transplant (allo-HSCT) Development Approach

GlobeNewswire
·
03 Mar

Alpha Metallurgical Resources Full Year 2024 Earnings: Revenues Disappoint

Simply Wall St.
·
02 Mar